![](/img/cover-not-exists.png)
P1.01-108 PACIFIC-6: A Phase II Study of Durvalumab Following Sequential Chemoradiotherapy in Patients with Stage III, Unresectable NSCLC
Garassino, M., Faivre-Finn, C., Mazieres, J., Reck, M., Emeribe, U., Franks, A., Trunova, N.Volume:
14
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.08.823
Date:
October, 2019
File:
PDF, 190 KB
2019